Skip to content

GeneDx Holdings WGS Operating margin

Operating margin at other companies

Natera, Inc. logo
Natera, Inc.NTRA
-13%+0.6pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-19.7%-8.6pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
8.8%-3.1pp
Quest Diagnostics logo
Quest DiagnosticsDGX
14.3%+0.6pp
Revvity logo
RevvityRVTY
12.4%-1.1pp
Labcorp Holdings logo
Labcorp HoldingsLH
10.2%+1.9pp

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

Based on trailing twelve months.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's operating margin?
GeneDx Holdings (WGS) reported operating margin of -14.9% in Q1 2026.
What is the long-term trend for GeneDx Holdings's operating margin?
Over 4 years (2020 to 2025), GeneDx Holdings's operating margin has grown at a -61.2% compound annual growth rate (CAGR), from -134.9% to -3.1%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.